The clinical success of exenatide is based on its ability to effectively mimic incretin effects, its resistance to DPP-4, and its longer duration of action compared to native human GLP-1
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or Gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Can I switch from Zepbound to Wegovy, or only between the diabetes versions
Weight loss injections, particularly GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro), have revolutionized obesity management, but questions about their cardiovascular safety remain a priority for patients and clinicians
During this time, you can relax while the glutathione works its magic